ST TSZY: Sodium Bicarbonate Injection passes the consistency evaluation of generic drugs
I'm PortAI, I can summarize articles.
ST TSZY's wholly-owned subsidiary Hubei TSZY Pharmaceutical recently received approval from the National Medical Products Administration, with sodium bicarbonate injection passing the consistency evaluation for generic drugs. This medication is primarily used for the nonspecific treatment of metabolic acidosis, alkalinizing urine, and certain drug overdoses. This move will enhance the market competitiveness of the drug and accumulate experience for the consistency evaluation of generic drugs for the company's other products
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments